1. Home
  2. AVTX vs ATPC Comparison

AVTX vs ATPC Comparison

Compare AVTX & ATPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • ATPC
  • Stock Information
  • Founded
  • AVTX 2011
  • ATPC 2016
  • Country
  • AVTX United States
  • ATPC Malaysia
  • Employees
  • AVTX N/A
  • ATPC N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • ATPC Medical/Nursing Services
  • Sector
  • AVTX Health Care
  • ATPC Health Care
  • Exchange
  • AVTX Nasdaq
  • ATPC Nasdaq
  • Market Cap
  • AVTX 57.4M
  • ATPC 68.0M
  • IPO Year
  • AVTX 2015
  • ATPC N/A
  • Fundamental
  • Price
  • AVTX $4.89
  • ATPC $1.47
  • Analyst Decision
  • AVTX Strong Buy
  • ATPC
  • Analyst Count
  • AVTX 7
  • ATPC 0
  • Target Price
  • AVTX $31.00
  • ATPC N/A
  • AVG Volume (30 Days)
  • AVTX 82.2K
  • ATPC 55.8K
  • Earning Date
  • AVTX 08-11-2025
  • ATPC 08-13-2025
  • Dividend Yield
  • AVTX N/A
  • ATPC N/A
  • EPS Growth
  • AVTX N/A
  • ATPC N/A
  • EPS
  • AVTX N/A
  • ATPC N/A
  • Revenue
  • AVTX $441,000.00
  • ATPC $1,293,141.00
  • Revenue This Year
  • AVTX N/A
  • ATPC N/A
  • Revenue Next Year
  • AVTX N/A
  • ATPC N/A
  • P/E Ratio
  • AVTX N/A
  • ATPC N/A
  • Revenue Growth
  • AVTX N/A
  • ATPC N/A
  • 52 Week Low
  • AVTX $3.39
  • ATPC $0.90
  • 52 Week High
  • AVTX $16.00
  • ATPC $6.80
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 54.89
  • ATPC 45.37
  • Support Level
  • AVTX $4.63
  • ATPC $1.37
  • Resistance Level
  • AVTX $5.02
  • ATPC $1.47
  • Average True Range (ATR)
  • AVTX 0.27
  • ATPC 0.09
  • MACD
  • AVTX 0.00
  • ATPC 0.02
  • Stochastic Oscillator
  • AVTX 72.73
  • ATPC 47.48

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About ATPC Agape ATP Corporation

Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. Its segments include: Skin care, health and wellness segment includes the provision of health and wellness products and health solution advisory services; and Green energy segment includes providing renewable energy products, technical solutions, installations and maintenance services. It derives maximum revenue from Skin care, health and wellness segment.

Share on Social Networks: